Own stocks of companies that get drugs approved. That hasn’t been so easy. But the U.S. Food & Drug Administration (FDA) has ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...